2Jame A, David A, Jane H, et al. Prognostic value of B-type natriuretic peptide in patients with acute coribart syndromes. N Eng J Med, 2001,345 (8): 1014-1021.
3Crilley, JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart. 2001, 86 (6) : 638-642.
4叶任高 陆再英.内科学第6版[M].北京:人民卫生出版社,2003.312.
5Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction, comparison with plasma atrial natriuretic peptide amt N-terminal proatrial natriuretic peptide. Circulation, 1996. 93(11) : 1963-1969.
6Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and antcomes of acute myocardial infarction. N Engl J Med, 2010, 362: 2155-2165.
8Buechel RR, Sommer G, Leibundgut G, et al. assessmerlt of left atrial funetiontal paramelers using a novel dedicated analysis tool for real- time three-dimensional echoeardiography: validalion in comparison to magnetic vesonanee imaging. Int J Cardiovasc Imaging, 2013, 29: 601- 608.
9Protti A, Dong X, Sirker A, et al. mri-based prediction of adverse cardiac remodeling after murine myocardial infarction. Am J Physiol Heart CirePhysiol, 2012, 303:H309-314.
